ACSL1+ microglia were more abundant in AD patients with the APOE4/4 genotype, and carrying the E4 mutation in the APOE gene has been identified as one of the most significant risk factors for the development of late-onset AD [45]. This evidence concerns the gene ACSL1 and Alzheimer disease.